The average Biofrontera stock price prediction forecasts a potential upside of 829.41% from the current BFRI share price of $8.50. That’s a massive leap over the company’s. As of this writing, more than 51 million shares of the stock have changed hands. BFRI stock is seeing heavy trading today alongside its patent news.Daily – Vickers Top Insider Picks for The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling. View real-time BFRI stock price and news, along with industry-best analysis. The shares and warrants included in the units are expected to begin trading on the Nasdaq Capital Market on October 29, 2021, under the ticker symbols “BFRI” and “BFRIW,” respectively.This is not a recommendation to buy or sell. Analyst's Disclosure: I/we have a beneficial long position in the shares of BFRI either through stock ownership, options, or other derivatives. I actually wanted to buy this stock on Dec 10 when the stock was at $3-4, and decided against it due to suspicion that the stock was being insanely pinned due to warrants being allowed to be exercisable immediately at an exercise price of $5.25 per share, which may have "pinned" the stock at least temporarily. Ticker Symbol: BFRI: Exchange: NASDAQ: Fiscal Year: January - December: Reporting Currency: USD: IPO Price: $5.00: CIK Code: 0001858685: CUSIP Number: 09077D100: ISIN. MOST SHORTED STOCK RIGHT NOW The float is 3.4 million, while the SHORT INTEREST is 3.05 million. Might as well be the GREATEST short squeeze before this year ends (NOT A FINANCIAL ADVICE, THIS STOCK WILL GO TO 0). Currency in USD Follow 2W 10W 9M 8.78 +0.22 (+2.57%) At close: 03:59PM EDT 1d 5d 1m 6m YTD 1y 5y Max Full screen BFRI, Biofrantera Inc. (BFRI) NasdaqCM - NasdaqCM Real Time Price. BFRI recently made its stock market debut through an initial public offering of 3.60 million units, each comprising one. subsidiary of German biopharmaceutical company Biofrontera AG. (BFRI) is a biopharmaceutical company that develops and sells dermatological products in the United States. What is the target price for Biofrontera (BFRI) stock? The latest price target for Biofrontera ( NASDAQ: BFRI) was reported by Benchmark on Wednesday, July 5, 2023.Should you be buying Biofrontera stock or one of its competitors? The main competitors of Biofrontera include Unicycive Therapeutics (UNCY), Sunshine Biopharma (SBFM), Chemomab Therapeutics (CMMB), AcelRx Pharmaceuticals (ACRX), Iterum Therapeutics (ITRM), Trevena (TRVN), Eterna Therapeutics (ERNA), Kazia Therapeutics. UNCY, SBFM, CMMB, ACRX, ITRM, TRVN, ERNA, KZIA, SHPH, and LIPO.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |